GSK plc
This role involves working within a team to design, discover, and engineer antibodies and proteins using yeast-based or phage display platforms combined with AI-driven in silico design approaches. The position focuses on optimizing antibodies into therapeutic grade leads and contributing to the development of first-in-class and best-in-class antibody-based medicines. The role requires collaboration across matrix teams and engagement with innovative technologies such as B-cell sorting, screening, and NGS.
Headquarters
London, England, United Kingdom
Company Size
10001+ employees
Founded
1830
At GSK, we unite science, technology and talent to get ahead of disease together
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for GSK plc.
GSK plc didn’t post a salary, so this is our estimate from similar listings.
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
Dec 19, 2025
Scientist , Antibody Engineering
Twist Bioscience
Scientist Antibody Discovery
Global Channel Management
Senior Scientist, Antibody Engineering & Discovery (BMD)
Pfizer
Scientist Antibody Discovery
St. Jude Children's Research Hospital
Principal Scientist, Biotherapeutics Discovery, Antibody Generation
Digital Biology
Research Senior Associate
Takeda Pharmaceutical Company Limited